Percutaneous left atrial appendage closure was non-inferior to non-vitamin K oral anticoagulants in preventing major cardiovascular or neurological events and may be considered in patients with an adequate rationale for non-pharmacological alternatives, according to results presented Monday at the European Society of Cardiology Congress 2019 in Paris.